Streptococcus pyogenes With Reduced Susceptibility to β-Lactams: How Big an Alarm Bell?

Clin Infect Dis. 2020 Jun 24;71(1):205-206. doi: 10.1093/cid/ciz1006.

Authors

William P Hanage¹, Samuel A Shelburne²

Affiliations

¹ Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
² Departments of Infectious Diseases and Genomic Medicine, MD Anderson Cancer Center, Houston, Texas, USA.

PMID: 31630163
DOI: 10.1093/cid/ciz1006

No abstract available

Publication types

Comment

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Humans
Microbial Sensitivity Tests
Mutation
Streptococcus pyogenes* / genetics
beta-Lactams* / pharmacology

Substances

Anti-Bacterial Agents
beta-Lactams